http://www.businesswire.com/news/home/20260530932788/en/Massive-Bio-Announces-Next-Generation-Reticulum-Nexus%E2%84%A2-Product-Suite-at-ASCO-2026 2026-05-30T07:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260529816966/en/Exelixis-Announces-Results-from-Subgroup-Analysis-of-Phase-3-CABINET-Pivotal-Trial-Evaluating-CABOMETYX%C2%AE-cabozantinib-in-Non-Functional-and-Functional-Neuroendocrine-Tumors-at-ASCO-2026 2026-05-30T07:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530490588/en/Global-Real-Assets-Trust-Reports-Q1-2026-Results 2026-05-30T06:31:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530865068/fr/ 2026-05-30T06:31:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530598089/en/Tempus-Launches-the-PRECISION-Challenge-a-National-Program-Opening-Its-Foundation-Model-Work-to-the-Broader-Research-Community 2026-05-30T05:30:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530259024/en/Incyte%E2%80%99s-Pivotal-frontMIND-Trial-Showed-Tafasitamab-Monjuvi%C2%AEMinjuvi%C2%AE-Combination-Significantly-Prolonged-Progression-free-Survival-Reducing-the-Risk-of-Disease-Progression-or-Death-by-25-in-Patients-with-Previously-Untreated-High-risk-DLBCL 2026-05-30T05:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530890115/en/Immunome-Announces-Detailed-Phase-3-RINGSIDE-Data-for-Varegacestat-in-Adults-with-Progressing-Desmoid-Tumors-at-the-2026-ASCO-Annual-Meeting 2026-05-30T05:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530052195/en/Tune-Therapeutics-Presents-Positive-Phase-1b2a-Proof-of-Concept-Data-on-TUNE-401-a-First-in-Class-Epigenetic-Silencer-for-Patients-with-Hepatitis-B-at-EASL-2026 2026-05-30T05:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530351488/en/TALZENNA-Plus-XTANDI-Improves-Radiographic-Progression-Free-Survival-by-More-Than-50-in-Metastatic-Prostate-Cancer 2026-05-30T05:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530829355/en/Tempus-Introduces-%E2%80%98Preview%E2%80%99-Bridging-the-Critical-Time-Gap-Between-Diagnostic-Order-and-Definitive-Results 2026-05-30T05:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530183615/en/ENZAMET-Trial-Shows-Veracytes-Decipher-Prostate-Test-Identifies-Which-Patients-Benefit-from-Adding-Chemotherapy-in-Metastatic-Prostate-Cancer 2026-05-30T05:00:00.000-07:00 weekly 0.5 http://www.businesswire.com/news/home/20260530544179/en/Encouraging-Global-Phase-II-Ivonescimab-Data-in-First-Line-Metastatic-Colorectal-Cancer-Presented-at-ASCO-2026 2026-05-30T05:00:00.000-07:00 weekly 0.5